Matches in SemOpenAlex for { <https://semopenalex.org/work/W2546885286> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2546885286 abstract "Abstract Abstract 5039 There is mounting evidence that malignant cells have an intrinsic ability to prevent apoptosis. In the present study we provide evidence that the ectopic expression of Apoptin can restore the failing apoptosis program in myeloma cells via protein kinase C b (PKCb) and overcome intrinsic or acquired resistance to cell death. Apoptin (VP3), a chicken anemia virus (CAV)-derived protein has been shown to possess tumor specific cytotoxicity; its expression induces apoptosis in human tumor and transformed cells but there is little or no cytotoxic effect in normal human cells or cell lines derived from different tissues including peripheral blood mononuclear cells, fibroblast and epithelial cells. Several studies have shown that the tumor specific killing of Apoptin correlates with its phosphorylation and its subcellular localization. In cancer cells, Apoptin is localized in the nucleus and is phosphorylated on threonine108 by an as yet unknown kinase, whereas in normal cells Apoptin is detected in the cytoplasm and is essentially unphosphorylated. We developed a lentiviral vector encoding a GFP-Apoptin fusion gene (LV-GFP-AP), which delivers the Apoptin gene efficiently to haematopoietic cells. Apoptin significantly and selectively killed a number of leukemia cell lines including K562, HL60, U937, KG1 and NB4. In particular, the dexamethasone resistant multiple myeloma cell line MM1.R and the dexamethasone sensitive cell line MM1.S were efficiently killed by Apoptin. In contrast normal CD34+ cells were not killed and maintained their differentiation potential in multilineage colony formation assays. In addition, we showed that the dexamethasone resistant MM1.R cells were considerably more susceptible to Apoptin induced cell death than the parental matched MM1.S cells. This correlated with increased phosphorylation and activation of the Apoptin protein in MM1.R cells. Expression profiling of MM1.R and MM1.S cells identified a number of differentially expressed kinases. PKCb was over-expressed 9 fold in MM1.R cells and we showed, by immunoprecipitation and in vivo kinase studies, that this kinase was responsible for Apoptin phosphorylation. Analysis of the Apoptin amino acid sequence for potential phosphorylation sites indicated seven putative phosphorylation sites corresponding to the PKC kinase consensus motifs (S/TXK/R or S/TXXK/R). These sites included Thr-108, which has been previously shown to be phosphorylated in tumor cells, but not in normal cells. In vitro studies showed that recombinant Apoptin protein was phosphorylated by recombinant GST-PKCb protein at the Thr-108 site. Addition of a PKCb specific inhibitor resulted in diminished Apoptin phosphorylation whilst an unrelated inhibitor had no such effect. Furthermore, shRNA knockdown or drug mediated inhibition of PKCb in vivo significantly reduced Apoptin phosphorylation. Finally, we found that Apoptin mediated cell death proceeded via the up-regulation of PKCb, activation of caspase-9/3, cleavage of the PKCd catalytic domain and down-regulation of MERTK and AKT protein kinases. Collectively these results demonstrate a novel pathway for Apoptin activation involving PKCb and PKCd. Our results show that Apoptin is able to effectively eliminate multiple myeloma cells which have become resistant to dexamethasone. In addition, this study has led to the identification of tumor specific cellular targets such as PKCb, whose modulation by shRNAs and small molecule drugs can induce strong anti-myeloma effects. Importantly, the evidence from our data suggests that protein kinase C inhibitors may have an important therapeutic role in plasma cell neoplasia. Disclosures: No relevant conflicts of interest to declare." @default.
- W2546885286 created "2016-11-11" @default.
- W2546885286 creator A5006098963 @default.
- W2546885286 creator A5020985573 @default.
- W2546885286 creator A5025545689 @default.
- W2546885286 creator A5032585809 @default.
- W2546885286 creator A5057770837 @default.
- W2546885286 creator A5064129923 @default.
- W2546885286 creator A5066009104 @default.
- W2546885286 creator A5087050238 @default.
- W2546885286 date "2010-11-19" @default.
- W2546885286 modified "2023-10-01" @default.
- W2546885286 title "Apoptin Induced Tumour Specific Killing Via Protein Kinase C Isoforms: A Potential Therapeutic Strategy In Plasma Cell Dyscrasias" @default.
- W2546885286 doi "https://doi.org/10.1182/blood.v116.21.5039.5039" @default.
- W2546885286 hasPublicationYear "2010" @default.
- W2546885286 type Work @default.
- W2546885286 sameAs 2546885286 @default.
- W2546885286 citedByCount "0" @default.
- W2546885286 crossrefType "journal-article" @default.
- W2546885286 hasAuthorship W2546885286A5006098963 @default.
- W2546885286 hasAuthorship W2546885286A5020985573 @default.
- W2546885286 hasAuthorship W2546885286A5025545689 @default.
- W2546885286 hasAuthorship W2546885286A5032585809 @default.
- W2546885286 hasAuthorship W2546885286A5057770837 @default.
- W2546885286 hasAuthorship W2546885286A5064129923 @default.
- W2546885286 hasAuthorship W2546885286A5066009104 @default.
- W2546885286 hasAuthorship W2546885286A5087050238 @default.
- W2546885286 hasConcept C121608353 @default.
- W2546885286 hasConcept C153911025 @default.
- W2546885286 hasConcept C154317977 @default.
- W2546885286 hasConcept C171122931 @default.
- W2546885286 hasConcept C190283241 @default.
- W2546885286 hasConcept C202751555 @default.
- W2546885286 hasConcept C2778903051 @default.
- W2546885286 hasConcept C31573885 @default.
- W2546885286 hasConcept C502942594 @default.
- W2546885286 hasConcept C54355233 @default.
- W2546885286 hasConcept C55493867 @default.
- W2546885286 hasConcept C81885089 @default.
- W2546885286 hasConcept C86803240 @default.
- W2546885286 hasConcept C95444343 @default.
- W2546885286 hasConcept C96232424 @default.
- W2546885286 hasConceptScore W2546885286C121608353 @default.
- W2546885286 hasConceptScore W2546885286C153911025 @default.
- W2546885286 hasConceptScore W2546885286C154317977 @default.
- W2546885286 hasConceptScore W2546885286C171122931 @default.
- W2546885286 hasConceptScore W2546885286C190283241 @default.
- W2546885286 hasConceptScore W2546885286C202751555 @default.
- W2546885286 hasConceptScore W2546885286C2778903051 @default.
- W2546885286 hasConceptScore W2546885286C31573885 @default.
- W2546885286 hasConceptScore W2546885286C502942594 @default.
- W2546885286 hasConceptScore W2546885286C54355233 @default.
- W2546885286 hasConceptScore W2546885286C55493867 @default.
- W2546885286 hasConceptScore W2546885286C81885089 @default.
- W2546885286 hasConceptScore W2546885286C86803240 @default.
- W2546885286 hasConceptScore W2546885286C95444343 @default.
- W2546885286 hasConceptScore W2546885286C96232424 @default.
- W2546885286 hasLocation W25468852861 @default.
- W2546885286 hasOpenAccess W2546885286 @default.
- W2546885286 hasPrimaryLocation W25468852861 @default.
- W2546885286 hasRelatedWork W1492143402 @default.
- W2546885286 hasRelatedWork W1523343097 @default.
- W2546885286 hasRelatedWork W1534952091 @default.
- W2546885286 hasRelatedWork W1974085932 @default.
- W2546885286 hasRelatedWork W2015157179 @default.
- W2546885286 hasRelatedWork W2048379956 @default.
- W2546885286 hasRelatedWork W2052592595 @default.
- W2546885286 hasRelatedWork W2066907948 @default.
- W2546885286 hasRelatedWork W2093051035 @default.
- W2546885286 hasRelatedWork W2131242974 @default.
- W2546885286 hasRelatedWork W2158996644 @default.
- W2546885286 hasRelatedWork W2195354147 @default.
- W2546885286 hasRelatedWork W2392821710 @default.
- W2546885286 hasRelatedWork W2512253488 @default.
- W2546885286 hasRelatedWork W2534189177 @default.
- W2546885286 hasRelatedWork W2549508243 @default.
- W2546885286 hasRelatedWork W2564423440 @default.
- W2546885286 hasRelatedWork W2573953675 @default.
- W2546885286 hasRelatedWork W2586256774 @default.
- W2546885286 hasRelatedWork W2588345982 @default.
- W2546885286 isParatext "false" @default.
- W2546885286 isRetracted "false" @default.
- W2546885286 magId "2546885286" @default.
- W2546885286 workType "article" @default.